Allarity Therapeutics, Inc. Faces Securities Fraud Lawsuit Amidst Allegations of Misconduct
Investors who recently placed their bets on Allarity Therapeutics, Inc. have now found themselves embroiled in a Securities Exchange Act saga. The class action lawsuit, as initiated by shareholders, accuses Allarity of breaching §§10(b) and 20(a) of the Act, along with the notorious Rule 10b-5 of the U.S. Securities and Exchange Commission. The allegations stem ...








